Valuation: Labcorp Holdings Inc.

Market Cap 25.88B 22.39B 20.91B 19.18B 36.08B 2,463B 36.65B 245B 96.29B 1,235B 97.2B 95.07B 4,082B P/E 2026 *
23.2x
P/E 2027 * 20.6x
Enterprise Value 31.06B 26.87B 25.09B 23.02B 43.29B 2,956B 43.98B 294B 116B 1,482B 117B 114B 4,898B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.96x
Free-Float
99.64%
Yield 2026 *
0.91%
Yield 2027 * 0.92%
1 day+0.83%
1 week+3.22%
Current month+3.22%
1 month+14.92%
3 months+25.60%
6 months+15.14%
Current year+27.22%
1 week 300.58
Extreme 300.58
319.94
1 month 262.1
Extreme 262.105
319.94
Current year 245
Extreme 245
319.94
1 year 244.52
Extreme 244.52
319.94
3 years 191.97
Extreme 191.97
319.94
5 years 191.97
Extreme 191.97
319.94
10 years 98.02
Extreme 98.02
319.94
Date Insider Type Main position Quantity % Market Cap.
8/4/26 A Sell

Responsable ventes & marketing

-924 0.0011%
8/3/26 A Sell

Controller/Auditor

-4,096 0.0050%
7/2/26 A Sell

EVP and President, Diagnostics

-234 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.83%+3.22%+20.06%+49.24% 25.88B
+21.37%+20.29%+111.98%+510.96% 46.43B
+0.04%+1.78%-19.56%-35.04% 7.76B
+6.20%+13.49%+35.65%+128.20% 5.69B
+0.19%+1.39%+21.09%+63.03% 3.39B
+10.76%+18.38%-26.68%+1,059.10% 2.3B
+6.49%+8.37%+185.69%+8.16% 2.13B
+11.67%+10.56%+32.06%+23.05% 2.02B
+3.35%+4.36%-4.07%-55.62% 1.99B
+3.62%+11.34%+28.61%-10.92% 1.84B
Average +6.45%+9.34%+38.48%+174.02% 9.94B
Weighted average by Cap. +11.32%+12.21%+63.20%+281.95%

Financials

2026 *2027 *
Net sales 14.75B 12.76B 11.91B 10.93B 20.56B 1,404B 20.88B 140B 54.86B 704B 55.39B 54.17B 2,326B 15.46B 13.38B 12.49B 11.46B 21.55B 1,472B 21.9B 147B 57.52B 738B 58.07B 56.8B 2,439B
Net income 1.13B 978M 913M 838M 1.58B 108B 1.6B 10.71B 4.2B 53.92B 4.24B 4.15B 178B 1.24B 1.07B 1B 920M 1.73B 118B 1.76B 11.77B 4.62B 59.26B 4.66B 4.56B 196B
Net Debt 5.18B 4.48B 4.18B 3.84B 7.21B 493B 7.33B 49.05B 19.25B 247B 19.44B 19.01B 816B 4.37B 3.78B 3.53B 3.24B 6.09B 416B 6.18B 41.38B 16.24B 208B 16.39B 16.04B 689B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
07/08/26 $319.17 +0.83% 429,351
06/08/26 $316.53 +0.82% 440,062
05/08/26 $313.96 +0.52% 502,483
04/08/26 $312.34 +1.60% 748,496
03/08/26 $307.42 -0.58% 727,010
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
319.17USD
Average target price
337.75USD
Spread / Average Target
+5.82%

Quarterly revenue - Rate of surprise